Finding the optimal recall rate in breast cancer screening: results from the ROCS study
Question Breast cancer screening requires a good balance between detection and false-positive rate. However, the interrelationship between these rates, and thus the optimal recall, is unknown. Findings Overall, the Dutch screening radiologists performed with high accuracy, and the current operating point optimizes the trade-off between cancer detection and false-positive recalls. Clinical relevance ROCS provides an efficient method to evaluate performance and determine target values based on data from screening practice. This method applies to various screening programs. Screening evaluation is essential for achieving and maintaining a positive benefit-to-harm ratio for participants.
Authors
- Tanya D. Geertse (ORCID: https://orcid.org/0000-0002-8603-488X)
- Maartje Smid-Geirnaerdt
- Ioannis Sechopoulos (ORCID: https://orcid.org/0000-0001-9615-8205)
- Craig K. Abbey
- Mireille J. M. Broeders
- Daniëlle van der Waal
Institutions
- Radboud University Nijmegen (NL)
- University of California, Santa Barbara (US)
- Radboud University Medical Center (NL)
- Amphia Ziekenhuis (NL)
- Dutch Expert Centre for Screening (NL)
- University of Twente (NL)
Publication Details
- Journal
- European Radiology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1007/s00330-026-12370-5
- Citations
- 1
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 52.10